Skip to main content
. 2023 Apr 20;10(17):2300552. doi: 10.1002/advs.202300552

Figure 5.

Figure 5

The role of EVs as endogenous carriers in treating A) head and neck squamous cell carcinoma, B) nasopharyngeal carcinoma, and C) chronic myeloid leukemia.